Viva Biotech Holdings (OTCMKTS:VBIZF) Sees Significant Increase in Short Interest

Viva Biotech Holdings (OTCMKTS:VBIZF) saw a large growth in short interest in May. As of May 15th, there was short interest totaling 75,000 shares, a growth of 3,650.0% from the April 30th total of 2,000 shares. Based on an average daily volume of 909 shares, the short-interest ratio is presently 82.5 days.

Viva Biotech Stock Down 2.7%

Shares of OTCMKTS:VBIZF traded down $0.01 on Wednesday, hitting $0.20. The stock had a trading volume of 1,000 shares, compared to its average volume of 1,000. Viva Biotech has a twelve month low of $0.20 and a twelve month high of $0.20. The firm’s 50 day moving average price is $0.31 and its 200-day moving average price is $0.29.

About Viva Biotech

Viva Biotech Ltd is a Shanghai-based contract research organization (CRO) providing integrated early-stage drug discovery services to the global pharmaceutical and biotechnology industries. The company’s offerings span target identification, fragment-based drug discovery, structure-based design, medicinal chemistry, high-throughput screening, in vitro ADME/Tox assays and antibody discovery. Viva Biotech leverages a proprietary fragment library and in-house structural biology capabilities to support hit identification and lead optimization across a broad range of therapeutic modalities.

With an emphasis on accelerating preclinical programs, the company combines X-ray crystallography, high-content cell-based assays and comprehensive pharmacokinetic profiling to help clients progress candidates from hit to lead.